EUVIMEDEUVIMED entdecken
Open Access

Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment

Toru Aoyama, Yukio Maezawa, Itaru Hashimoto, Ryuki Esashi, Sosuke Yamamoto, Keisuke Kazama, Koji Numata, Mamoru Uchiyama, Ayako Tamagawa, Aya Saito, Norio Yukawa

In Vivo · 2024

DOI: 10.21873/invivo.13775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Toru Aoyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yokohama City University, Yokohama, Japan t-aoyama@lilac.plala.or.jp. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: We hypothesized that the inflammatory burden index (IBI) is a promising biomarker for esophageal cancer (EC) treatment and management. To confirm our hypothesis, we evaluated the prognostic impact of IBI in patients with EC who received curative treatment. PATIENTS AND METHODS: We conducted a retrospective review of medical records and collected data from consecutive patients with EC who underwent curative resection at Yokohama City University between 2005 and 2020. The IBI score was calculated as the C-reactive protein level multiplied by the neutrophil-to-lymphocyte ratio. RESULTS: In total, 180 patients with EC were included in this study. The 3- and 5-year overall survival (OS) rates were 72.9% and 63.4%, respectively, in the IBI-low group, and 38.2% and 32.5% in the IBI-high group (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsInflammationHumansMaleFemalePrognosisMiddle AgedAgedRetrospective StudiesNeutrophilsC-Reactive ProteinLymphocytesBiomarkers, TumorAdultAged, 80 and overNeoplasm Staging

Stichwörter der Autor:innen

Inflammatory burden indexesophageal cancersurvival

Substanzen

C-Reactive ProteinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Yokohama City University, Yokohama, Japan t-aoyama@lilac.plala.or.jp.
  • Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Department of Surgery, Yokohama City University, Yokohama, Japan itarum1n1@hotmail.com.

Zitieren

APA

Aoyama, T., Maezawa, Y., Hashimoto, I., Esashi, R., Yamamoto, S., Kazama, K., Numata, K., Uchiyama, M., Tamagawa, A., Saito, A., & Yukawa, N. (2024). Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment. In Vivo. https://doi.org/10.21873/invivo.13775

Vancouver

Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Yamamoto S, Kazama K, et al. Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment. In Vivo. 2024. doi:10.21873/invivo.13775

BibTeX
@article{Aoyama2024,
  author = {Aoyama, Toru and Maezawa, Yukio and Hashimoto, Itaru and Esashi, Ryuki and Yamamoto, Sosuke and Kazama, Keisuke and Numata, Koji and Uchiyama, Mamoru and Tamagawa, Ayako and Saito, Aya and Yukawa, Norio},
  title = {Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13775}
}
Kostenlos starten →